advertisement

Topcon

Stalmans I 25

Showing records 1 to 25 | Display all abstracts from Stalmans I

106555 Progression of functional and structural glaucomatous damage in relation to diurnal and nocturnal dips in mean arterial pressure
Melgarejo JD
Frontiers in cardiovascular medicine 2022; 9: 1024044
106729 The natural history of untreated ocular hypertension and glaucoma
Lauwers A
Survey of Ophthalmology 2023; 68: 388-424
105160 Trabeculectomy with mitomycin C alone or coupled with intracamerular bevacizumab? A 2-year comparative study
José P
British Journal of Ophthalmology 2022; 106: 1399-1405
106729 The natural history of untreated ocular hypertension and glaucoma
Barbosa Breda J
Survey of Ophthalmology 2023; 68: 388-424
105160 Trabeculectomy with mitomycin C alone or coupled with intracamerular bevacizumab? A 2-year comparative study
Teixeira FJ
British Journal of Ophthalmology 2022; 106: 1399-1405
106555 Progression of functional and structural glaucomatous damage in relation to diurnal and nocturnal dips in mean arterial pressure
Eijgen JV
Frontiers in cardiovascular medicine 2022; 9: 1024044
106729 The natural history of untreated ocular hypertension and glaucoma
Stalmans I
Survey of Ophthalmology 2023; 68: 388-424
105160 Trabeculectomy with mitomycin C alone or coupled with intracamerular bevacizumab? A 2-year comparative study
Barão R
British Journal of Ophthalmology 2022; 106: 1399-1405
106555 Progression of functional and structural glaucomatous damage in relation to diurnal and nocturnal dips in mean arterial pressure
Wei D; Maestre GE
Frontiers in cardiovascular medicine 2022; 9: 1024044
105160 Trabeculectomy with mitomycin C alone or coupled with intracamerular bevacizumab? A 2-year comparative study
Sousa DC
British Journal of Ophthalmology 2022; 106: 1399-1405
106555 Progression of functional and structural glaucomatous damage in relation to diurnal and nocturnal dips in mean arterial pressure
Al-Aswad LA
Frontiers in cardiovascular medicine 2022; 9: 1024044
105160 Trabeculectomy with mitomycin C alone or coupled with intracamerular bevacizumab? A 2-year comparative study
Marques RE; Barata ADO
British Journal of Ophthalmology 2022; 106: 1399-1405
106555 Progression of functional and structural glaucomatous damage in relation to diurnal and nocturnal dips in mean arterial pressure
Liao CT
Frontiers in cardiovascular medicine 2022; 9: 1024044
105160 Trabeculectomy with mitomycin C alone or coupled with intracamerular bevacizumab? A 2-year comparative study
Marques-Neves C
British Journal of Ophthalmology 2022; 106: 1399-1405
106555 Progression of functional and structural glaucomatous damage in relation to diurnal and nocturnal dips in mean arterial pressure
Mena LJ
Frontiers in cardiovascular medicine 2022; 9: 1024044
105160 Trabeculectomy with mitomycin C alone or coupled with intracamerular bevacizumab? A 2-year comparative study
Alves M
British Journal of Ophthalmology 2022; 106: 1399-1405
106555 Progression of functional and structural glaucomatous damage in relation to diurnal and nocturnal dips in mean arterial pressure
Vanassche T
Frontiers in cardiovascular medicine 2022; 9: 1024044
105160 Trabeculectomy with mitomycin C alone or coupled with intracamerular bevacizumab? A 2-year comparative study
Papoila AL
British Journal of Ophthalmology 2022; 106: 1399-1405
106555 Progression of functional and structural glaucomatous damage in relation to diurnal and nocturnal dips in mean arterial pressure
Janssens S
Frontiers in cardiovascular medicine 2022; 9: 1024044
105160 Trabeculectomy with mitomycin C alone or coupled with intracamerular bevacizumab? A 2-year comparative study
Stalmans I
British Journal of Ophthalmology 2022; 106: 1399-1405
106555 Progression of functional and structural glaucomatous damage in relation to diurnal and nocturnal dips in mean arterial pressure
Verhamme P; Keer KV
Frontiers in cardiovascular medicine 2022; 9: 1024044
105160 Trabeculectomy with mitomycin C alone or coupled with intracamerular bevacizumab? A 2-year comparative study
Silva JP
British Journal of Ophthalmology 2022; 106: 1399-1405
106555 Progression of functional and structural glaucomatous damage in relation to diurnal and nocturnal dips in mean arterial pressure
Stalmans I
Frontiers in cardiovascular medicine 2022; 9: 1024044
105160 Trabeculectomy with mitomycin C alone or coupled with intracamerular bevacizumab? A 2-year comparative study
Abegão Pinto L
British Journal of Ophthalmology 2022; 106: 1399-1405
106555 Progression of functional and structural glaucomatous damage in relation to diurnal and nocturnal dips in mean arterial pressure
Zhang ZY
Frontiers in cardiovascular medicine 2022; 9: 1024044

Issue 23-3

Change Issue


advertisement

Topcon